Abstract: The present invention relates to a hepcidin antagonist for use in the treatment of inflammatory diseases.
Type:
Application
Filed:
March 14, 2016
Publication date:
March 1, 2018
Applicants:
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), CENTRENATIONAL DE LA RECHERCHE SCIENTIFIQUE -CNRS, UNIVERSITE PARIS DESCARTES, UNIVERSITE PRIS DIDEROT- PARIS 7
Inventors:
Carole PEYSSONNAUX, Jacques MATHIEU, Sara ZUMERLE